Investor

HBM BioCapital

Last cheque observed May 2011. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietInvestment firm

Series ASeries BSeries C

Cheques on record
0%of best year0cheques in 12 months, 7 on record
Since the last cheque5655days00hrs00min00sec
Median round$22MRounds led0 of 7Exits2 from the portfolioMostly inSwitzerland, 57%
Pitch HBM BioCapital

HBM BioCapital highlights

  1. 01

    7 rounds on record

  2. 02

    Mostly Series A and Series B: 57% of its rounds

  3. 03

    2 exits from the portfolio

What they do

Type
Investment firm (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first7 appearances

  1. 2011

    1 round

  2. May
    Delenex TherapeuticsSeries A · CH · finsmes.com$19MWith 5 others
  3. 2010

    1 round

  4. Nov
    Delenex TherapeuticsSeries A · CH · finsmes.com$14MWith 4 others
  5. 2009

    1 round

  6. Oct
    MTM LaboratoriesSeries C · US · mtmlabs.com$57MWith 3 others
  7. 2008

    2 rounds

  8. Aug
    Anthera PharmaceuticalsVenture · US$19MWith 5 others
  9. Aug
    ESBATechSeries B · CH · fiercebiotech.com$22MWith 7 others
  10. 2006

    1 round

  11. Aug
    ESBATechSeries B · CH · esbatech.com$41MWith 6 others
  12. 2005

    1 round

  13. Oct
    Nereus PharmaceuticalsSeries D · US$43MWith 11 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

MTM LaboratoriesBought by RocheUndisclosedJul 2011
Anthera PharmaceuticalsListedUndisclosedMar 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as HBM BioCapital. A count of rooms they were both in, not a relationship either has claimed.

HBM BioVenturesGrowth equity6rounds togetherBioMedPartnersPrivate equity4rounds togetherSV Life SciencesVC firm4rounds togetherVI PartnersVC firm4rounds togetherClarus VenturesVC firm2rounds togetherNovartis Venture FundCorporate VC2rounds together

Quick answers about HBM BioCapital

What does HBM BioCapital invest in?

HBM BioCapital invests most often at Series A and Series B (57% of the rounds on record).

How active is HBM BioCapital?

7 investments on record, 0 of them in the last 12 months. The most recent was in May 2011.

How big are HBM BioCapital's cheques?

The median round it joins is $22M.

Does HBM BioCapital lead rounds?

Rarely, if at all: none of its 7 investments on record names it as the lead.

Where does HBM BioCapital invest?

Most of the companies it backs are in Switzerland (57%) and the United States (43%).

Is HBM BioCapital investing now?

No investments in the last 12 months; the latest was in May 2011.

Who does HBM BioCapital invest alongside?

Most often HBM BioVentures (6 rounds together), BioMedPartners (4 rounds together) and SV Life Sciences (4 rounds together).

What kind of investor is HBM BioCapital?

HBM BioCapital is an investment firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it